Collaboration | Status | WG | |
Congenital nephrotic syndrome | ESPN | EJHG 2020 | Hereditary GP |
Cystinuria | eUROGEN | KI 2021 | Metabolic nephropathies |
Bartter syndrome | NRN 2021 | Tubulopathies | |
Distal renal tubular acidosis | ESPN | NDT 2021 | Tubulopathies |
Nephrogenetic diagnostics | ERA-EDTA |
| Taskforce molecular diagnostics |
Monoclonal gammopathies of renal significance | EuroBloodNet | Paper in preparation | Immune GP |
Kidney dysplasia | Paper in preparation | Renal malformations | |
Obstructive uropathies | eUROGEN | Prenatal part submitted NRU Postnatal part in preparation | Renal malformations |
ADPKD management | ERA-EDTA | In planning | AD structural disorders |
Dent disease | Under development | Metabolic nephropathies | |
Nephrogenic diabetes insipidus | Under development | Tubulopathies | |
Tuberous Sclerosis Complex |
| Under development | AD structural disorders |
Bardet-Biedl Syndrome |
| Under development | Renal malformations |
Apheresis |
| Under development | Pediatric CKD/Dialysis |
Renal hypomagnesemia | ESPN/ERA-EDTA | In planning | Tubulopathies |
IgA nephropathy in children | IPNA | In planning | Immune GP |
Consensus paper on genetic testing in adult patients; what are the pros and cons; when and why? |
| In planning | Immune GP |
Renal amyloidosis |
| In planning | Immune GP |
Cryoglobulinemic glomerulonephritis |
| In planning | Immune GP |
Methylmalonic acidemia | MetabERN | In planning | Metabolic nephropathies |
Hyperoxaluria | Oxaleurope | In planning | Metabolic nephropathies |
ACEi/ARB in CKD |
| In planning | Pediatric CKD/Dialysis |
Cardiovascular evaluation and management in pediatric CKD | WG Dialysis and Tx | In planning | Pediatric CKD/Dialysis |
Practical guideline on treatment of STEC-HUS’ |
| In planning | TMA |